Edluar the second US launch for Meda in two months
This article was originally published in Scrip
Executive Summary
Meda Pharmaceuticals has launched its second new product in the US in two months – its sublingual formulation of zolpidem tartrate (Edluar), 5mg and 10mg tablets. Last month, it launched a higher dose formulation (0.15%) of its nasal antihistamine spray, Astepro (azelastine).